Company

Taro Pharmaceutical Industries Ltd.

Headquarters: Haifa, Israel

Founded: 1950 in Haifa, Israel

Employees: 1,417

CEO: Mr. Uday V. Baldota

NYSE: TARO

Market Cap

$1.62 Billion

USD as of June 1, 2024

Market Cap History

Taro Pharmaceutical Industries Ltd. market capitalization over time

Evolution of Taro Pharmaceutical Industries Ltd. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Taro Pharmaceutical Industries Ltd.

Detailed Description

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Taro Pharmaceutical Industries Ltd. has the following listings and related stock indices.


Stock: NYSE: TARO wb_incandescent

Stock: FSX: TAL wb_incandescent

Key People

Uday Vijaykumar Baldota, CEO

Financials

Revenue: US$ 862.94 million (2015)

Operating income: US$ 527.63 million (2015)

Net income: US$ 484.26 million (2015)


Total assets: US$ 1,737.74 million (2015)

Total equity: US$ 1,411.72 million (2015)

Details

Headquarters:

14 Hakitor Street

Haifa Bay

Haifa, 2624761

Israel

Phone: 972 4 847 5700